PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response Shinhan Financial Group Q4 2025 Earnings Heavy EPS Miss Despite Modest Share Gain Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline BHP Q1 2026 Earnings EPS Falls Short of Estimates Amid Commodity Headwinds Pyxis Tankers Q1 2026 Earnings Strong EPS Beat Amidst Soft Share Reaction ZENA Q4 2025 Earnings Deep Loss Misses Estimates Yet Shares Rally on Strategic Updates VEON Q1 2026 Earnings Earnings Beat Expectations Despite Lack of Revenue Disclosure LXP Industrial Trust Q1 2026 Earnings Missed EPS Estimate as Negative Earnings Reported EFSCP Q1 2026 Earnings Preferred Stock Steady as Common EPS Misses Estimates Cognition Therapeutics Inc CGTX Q1 2026 Earnings Narrower Loss on Lower Expenses No Revenue Reported Provident Financial Holdings Inc PROV Q1 2026 Earnings EPS Misses Estimates as Stock Barely Moves NTLA Q1 2026 Earnings Narrowerthanexpected loss signals continued progress in gene editing pipeline